These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience. Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834 [TBL] [Abstract][Full Text] [Related]
5. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175 [TBL] [Abstract][Full Text] [Related]
6. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma]. Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674 [TBL] [Abstract][Full Text] [Related]
7. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Pow EH; Kwong DL; McMillan AS; Wong MC; Sham JS; Leung LH; Leung WK Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):981-91. PubMed ID: 17145528 [TBL] [Abstract][Full Text] [Related]
8. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord. Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826 [TBL] [Abstract][Full Text] [Related]
9. Comparing 3DCRT and inversely optimized IMRT planning for head and neck cancer: equivalence between step-and-shoot and sliding window techniques. Longobardi B; De Martin E; Fiorino C; Dell'oca I; Broggi S; Cattaneo GM; Calandrino R Radiother Oncol; 2005 Nov; 77(2):148-56. PubMed ID: 16260056 [TBL] [Abstract][Full Text] [Related]
11. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program. Vergeer MR; Doornaert PA; Rietveld DH; Leemans CR; Slotman BJ; Langendijk JA Int J Radiat Oncol Biol Phys; 2009 May; 74(1):1-8. PubMed ID: 19111400 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma. Daly ME; Lieskovsky Y; Pawlicki T; Yau J; Pinto H; Kaplan M; Fee WE; Koong A; Goffinet DR; Xing L; Le QT Head Neck; 2007 Mar; 29(3):211-20. PubMed ID: 17111429 [TBL] [Abstract][Full Text] [Related]
13. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing. Rosenthal DI; Chambers MS; Weber RS; Eisbruch A Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519 [TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy. Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501 [TBL] [Abstract][Full Text] [Related]
15. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Feng FY; Kim HM; Lyden TH; Haxer MJ; Feng M; Worden FP; Chepeha DB; Eisbruch A Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1289-98. PubMed ID: 17560051 [TBL] [Abstract][Full Text] [Related]
16. Reducing the risk of xerostomia and mandibular osteoradionecrosis: the potential benefits of intensity modulated radiotherapy in advanced oral cavity carcinoma. Ahmed M; Hansen VN; Harrington KJ; Nutting CM Med Dosim; 2009; 34(3):217-24. PubMed ID: 19647632 [TBL] [Abstract][Full Text] [Related]
17. Intensity modulated radiotherapy improves target coverage and parotid gland sparing when delivering total mucosal irradiation in patients with squamous cell carcinoma of head and neck of unknown primary site. Bhide S; Clark C; Harrington K; Nutting CM Med Dosim; 2007; 32(3):188-95. PubMed ID: 17707198 [TBL] [Abstract][Full Text] [Related]
18. Conventional, conformal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: The impact of tumor regression. van de Bunt L; van der Heide UA; Ketelaars M; de Kort GA; Jürgenliemk-Schulz IM Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):189-96. PubMed ID: 15978745 [TBL] [Abstract][Full Text] [Related]
19. Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function. Saarilahti K; Kouri M; Collan J; Hämäläinen T; Atula T; Joensuu H; Tenhunen M Radiother Oncol; 2005 Mar; 74(3):251-8. PubMed ID: 15763305 [TBL] [Abstract][Full Text] [Related]
20. Dynamic intensity-modulated non-coplanar arc radiotherapy (INCA) for head and neck cancer. Krayenbuehl J; Davis JB; Ciernik IF Radiother Oncol; 2006 Nov; 81(2):151-7. PubMed ID: 17055095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]